000 | 01802 a2200517 4500 | ||
---|---|---|---|
005 | 20250517043406.0 | ||
264 | 0 | _c20161213 | |
008 | 201612s 0 0 eng d | ||
022 | _a1756-3305 | ||
024 | 7 |
_a10.1186/s13071-015-1000-5 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aCheng, Wei-Hung | |
245 | 0 | 0 |
_aNitric oxide maintains cell survival of Trichomonas vaginalis upon iron depletion. _h[electronic resource] |
260 |
_bParasites & vectors _cJul 2015 |
||
300 |
_a393 p. _bdigital |
||
500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't | ||
650 | 0 | 4 | _aAdaptation, Physiological |
650 | 0 | 4 | _aAnimals |
650 | 0 | 4 | _aBase Sequence |
650 | 0 | 4 | _aBenzimidazoles |
650 | 0 | 4 | _aCarbocyanines |
650 | 0 | 4 |
_aCell Survival _xdrug effects |
650 | 0 | 4 |
_aEnzyme Inhibitors _xpharmacology |
650 | 0 | 4 | _aHigh-Throughput Nucleotide Sequencing |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 | _aIron Deficiencies |
650 | 0 | 4 |
_aLeupeptins _xpharmacology |
650 | 0 | 4 | _aModels, Biological |
650 | 0 | 4 |
_aNitric Oxide _xpharmacology |
650 | 0 | 4 |
_aNitric Oxide Synthase _xantagonists & inhibitors |
650 | 0 | 4 |
_aProtozoan Proteins _xantagonists & inhibitors |
650 | 0 | 4 |
_aReactive Oxygen Species _xpharmacology |
650 | 0 | 4 | _aSequence Analysis, RNA |
650 | 0 | 4 | _aTranscriptome |
650 | 0 | 4 |
_aTrichomonas Infections _xparasitology |
650 | 0 | 4 |
_aTrichomonas vaginalis _xdrug effects |
650 | 0 | 4 |
_aomega-N-Methylarginine _xpharmacology |
700 | 1 | _aHuang, Kuo-Yang | |
700 | 1 | _aHuang, Po-Jung | |
700 | 1 | _aHsu, Jo-Hsuan | |
700 | 1 | _aFang, Yi-Kai | |
700 | 1 | _aChiu, Cheng-Hsun | |
700 | 1 | _aTang, Petrus | |
773 | 0 |
_tParasites & vectors _gvol. 8 _gp. 393 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1186/s13071-015-1000-5 _zAvailable from publisher's website |
999 |
_c25103641 _d25103641 |